Skip to main content

Advertisement

Fig. 3 | Cancer Communications

Fig. 3

From: Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?

Fig. 3

Kaplan–Meier survival curves of patients with lower risk (Memorial Sloan-Kettering Cancer Center clinical risk score [MSKCC-CRS] of 0–2) or higher risk (MSKCC-CRS 3–5) for chemotherapy, stratified by the administration of adjuvant chemotherapy (ACT). a Recurrence-free survival (RFS) in the lower-risk group; b overall survival (OS) in the lower-risk group 2; c RFS in the higher risk group; and d OS in the higher risk group

Back to article page